Aim: Our aim is to provide expected outcomes for undergoing manual removal of placenta (MROP) following vaginal delivery in women having an unpredictable adherent placenta (AP). Methods: The data were obtained from four hospitals in Miyazaki Prefecture, Japan. We used propensity score-matched (1:1) analysis to match women who underwent MROP with women who did not undergo MROP (control). Total blood loss and hemorrhagic rate used as a ratio of women who reached a certain amount of blood loss were compared. Subgroup analysis was undertaken and was dependent on the presence of AP. We found the cut-off value of blood loss for detecting AP. Results: Thirty-seven MROP cases were identified. Total blood loss and hemorrhagic rate differed significantly between MROP cases and controls; 95% of controls had blood loss of 1000 mL or less, whereas for the MROP cases, it was 14%. Fourteen MROP cases were diagnosed with AP. The hemorrhagic rate differed significantly between MROP cases with and without AP (n = 19); 79% of MROP cases without AP had blood loss of 2000 mL or less, whereas for the MROP cases with AP, it was 7%. There were seven incidents of hysterectomy and two of arterial embolization in MROP cases with AP. Through receiver operating characteristic curve analysis, 2035 mL of blood loss was determined to be the optimal cut-off value for detecting AP. Conclusion: The incidence of unpredictable AP in MROP cases was as high as 38%. The morbidity of MROP cases with unpredictable AP was severe. MROP should be prohibited in the absence of appropriate hemostatic preparations.
Introduction
Obstetric hemorrhage is a leading problem that continues to beset obstetricians. Maternal deaths surveys in Japan indicate that half of the maternal deaths are due to obstetric hemorrhage. 1, 2 Given the surveys conducted on maternal deaths or near-miss cases, the importance of identifying differences in morbidity with respect to risk factors, timely adequate blood transfusion and multidisciplinary protocols for hemostasis has been emphasized. [3] [4] [5] [6] When a placenta is not delivered within 30 min after vaginal delivery, and unless an adherent placenta (AP) is strongly suspected before parturition, obstetricians usually attempt the manual removal of placenta (MROP). 7 A longer third stage of labor leads to an increased amount of bleeding at this stage and subsequently requires blood transfusion or dilatation and curettage. 8, 9 In fact, the prevalence of retained placentas reached 0.1-3.3%, with maternal deaths reported to be as high as 10%. 7 Following this, it was believed that timely MROP after delivery may reduce maternal morbidity. However, there is little evidence to support the notion that MROP should be performed when the placenta has not been delivered after delivery. 10 In addition, MROP sometimes causes severe post-partum hemorrhage. 11 Women who underwent MROP after vaginal delivery and where AP was not suspected antenatally may be at higher risk of maternal death in cases of retained placenta. Nevertheless, very little data exist concerning the series of complications following MROP. 11, 12 When searching PubMed with the phrases 'manual removal of placenta' and 'randomized control trial' and designating the years 1990-2018 as our preferred filter range, results showed that there were no randomized control trials during that period that focused on MROP in terms of its effectiveness and limitations in women where AP was not suspected antenatally.
We therefore conducted a retrospective cohort study of women who underwent MROP after vaginal delivery and where AP was not suspected antenatally in an effort to evaluate complications following MROP. Our results will provide sufficiently predictable outcomes for women having unpredictable AP undergoing MROP.
Methods
This study was undertaken retrospectively, and approval (#2018-O-0313) was obtained from the constituted ethics committee of the University of Miyazaki. The medical charts of women admitted to the University of Miyazaki, Miyazaki Medical Association Hospital, Nobeoka Prefectural Miyazaki Hospital and Miyakonojyo Medical Center from November 2007 to November 2017 who underwent MROP after vaginal delivery and where AP was not suspected antenatally were retrospectively examined. The University of Miyazaki is a tertiary center, whereas Miyazaki Medical Association Hospital, Nobeoka Prefectural Miyazaki Hospital and Miyakonojyo Medical Center are secondary centers.
During the study period, when a placenta was not delivered within 30 min after vaginal delivery and unless AP was strongly suspected before delivery, attending physicians attempted MROP in either an operating room or delivery room. In the operating room, women had intravenous anesthesia with or without the addition of sevoflurane for uterine relaxation to ease MROP. In cases of intractable bleeding following MROP, these women underwent cesarean hysterectomy or uterine artery embolization, depending on the convenience of the facility and judgment of attending physicians.
We excluded cases with multifetal pregnancies, previous MROP and known uterine anomalies from the study. We then identified cases of MROP after vaginal delivery during the study period. The following maternal demographic data were collected: maternal age, parity (primipara), history of abortion, history of having assisted reproductive technology including artificial insemination with partner's semen or embryo transfer (ART) and gestational age at delivery (weeks). Maternal adverse outcomes were investigated and included evaluations of total blood loss at delivery, presence of AP, blood product transfusions, invasive treatment including hysterectomy and uterine artery embolization. Total blood loss at delivery included blood loss at delivery and up to 2 h after delivery. When MROP treatment lasted for more than 2 h, the total blood loss was considered to be the sum of blood loss at birth plus the blood loss during treatment. In this study, the 'hemorrhagic rate' was also investigated and was defined as the ratio of women who displayed a certain amount of blood loss. Pathologists determined the confirmation of AP and chorioamnionitis following delivery. The three gradations of AP are as follows: placenta accreta vera, in which placental villi embed directly onto superficial myometrium in the absence of decidua; in placenta accreta, in which placental villi are found deeper in the myometrium and in placenta percreta, in which placental villi have penetrated through the uterine serosa. 13 When the specimen comprised only the placenta, and direct attachment between villi and muscular layer without the decidual layer was confirmed by histological examination, it was regarded as accreta vera.
We used propensity score-matched (1:1) analysis to match women who underwent MROP after vaginal delivery with women who did not undergo MROP (control) for observed confounding factors that might influence both group assignment and outcome. Controls who gave birth during the same study period at the University of Miyazaki were selected. The propensity score was defined as the maternal probability of undertaking MROP based on the patients' individual observed covariates. Probability was estimated using a logistic regression model, with MROP as the dependent variable in relation to the following baseline obstetrical characteristics: maternal age, parity, history of abortion, history of ART and gestational age at delivery. The analysis for total blood loss and hemorrhagic rate was based on this propensity matching. Analysis of the matched set was performed after checking for imbalance of matching. Cases of MROP were also divided into two subgroups according to the presence of AP and the hemorrhagic rate, and the incidence of adverse outcomes was compared. The cut-off value of total blood loss was examined to distinguish between those MROP cases with and without AP.
Comparisons between groups were made using the Kaplan-Meier with log-rank test, receiver operating characteristic curve (ROC) analysis, Welch's t-test or χ 2 tests. Data are expressed as number, incidence (%), range or mean AE SD. Probability values less than 0.05 were considered significant.
Results
We identified 37 cases of MROP after vaginal delivery during the study period. The mean maternal age of the study group was 31 AE 5.8 years, and gestational age at delivery was 38 AE 3.1 weeks. The percentage of primipara pregnancies was 41%, and the percentage of history of abortion was 54%. The percentage of having ART was high as 11% in MROP cases. At baseline, there were no significant differences between MROP cases and controls in terms of maternal age, parity, history of abortion, history of ART or gestational age at delivery ( Table 1) .
The mean blood loss in MROP cases was 3076 AE 3415 mL (range: 380-19 070 mL) and was significantly higher than that of controls (495 AE 263 mL, range: 149-1284 mL) (P < 0.01). The hemorrhagic rate also differed significantly between MROP cases and controls (P < 0.01, Fig. 1 ). In particular, 95% of controls had blood loss of 1000 mL or less, whereas that of MROP cases was only 14%.
Of the 37 MROP cases, 14 (38%) were diagnosed with AP (Table 2) . Four cases of MROP were not available for placental histological examination following delivery. The percentage of history of abortion and history of ART did not differ significantly between MROP cases with and without AP. The mean blood loss of MROP cases with AP was 5136 AE 4632 mL, while that of MROP cases without AP was 1755 AE 1551 mL. The hemorrhagic rate differed significantly between MROP cases with and without AP (P < 0.01, Fig. 2) . In particular, 79% of MROP cases without AP had blood loss of 2000 mL or less, while MROP with AP comprised only 7% of cases. Seven MROP cases with AP eventually underwent hysterectomy ( Fig. 2; arrow head) , and two MROP cases with AP underwent arterial embolization ( Fig. 2; small arrow) . One MROP case with AP having intractable bleeding followed by temporal cardiac arrest was diagnosed with amniotic fluid embolism in the uterine corpus ( Fig. 2 ; large arrow). There were no cases of hysterectomy or embolization among the 18 MROP cases without AP. However, the hemorrhagic rate differed significantly between MROP cases without AP and controls (P < 0.01)
The optimal cut-off value of blood loss for detecting AP in MROP cases was calculated using an ROC curve. As seen from the ROC curve in Figure 3 , the area under the curve was 0.88, with statistical significance (P < 0.01), and the shortest distance from the upper left corner and the maximum product of sensitivity and specificity was at 2035 mL (sensitivity 0.93, specificity 0.78). On the other hand, the sensitivity and specificity of 1925 mL were 0.93 and 0.67, respectively. The sensitivity and specificity of 2315 mL were 0.86 and 0.78, respectively.
Discussion
The causes of retained placenta are roughly divided into three etiologies: failed uterine contraction without Results are expressed as number, mean AE SD, or incidence (%). and ART, assisted reproductive technology, including artificial insemination with husband's semen or embryo transfer; MROPs, women having manual removal of placenta.
placental abnormality, entrapment of placenta due to a closing cervix or AP. 7 Thus, although AP has been known as a risk factor for retained placenta, few reports are available that specifically detail its prevalence. According to Andrew D, around one in 440 women with retained placenta following vaginal delivery will have placenta accreta. 7 In the current study, at least 38% of women who underwent MROP were diagnosed with AP. The difference in incidence may also be partially related to variations of AP. We noticed 13 cases of accreta vera and only 1 case of placenta increta in our study group. As accreta vera cannot be determined by visual examination, pathological diagnosis of delivered placenta is necessary. Consequently, there will be a difference in reported frequency. We also excluded cases with known risk factors for AP, such as previous MROP or uterine anomalies, from our study group. Even so, the 38% incidence of AP was extremely high. It was subsequently thought that this high frequency of unpredictable AP must be exacerbating the prognosis of retained placenta. In fact, the morbidity of MROP cases with AP was extremely high in the current study. Given this, we have to be aware of the peculiarly high incidence of AP in cases of retained placenta and the high morbidity rate following MROP with unanticipated AP.
In contrast, morbidity was less severe in MROP cases without AP compared to MROP cases with AP. There were no cases of hysterectomy or arterial embolization in our series. This is due in part to the fact that MROP cases without AP may have entrapment of placenta due to a closing cervix or failed uterine contraction without placental abnormalities. However, the total blood loss was still significantly higher than the controls. According to a national survey for blood loss of singleton at vaginal delivery in Japan, 95.4% of Japanese women had a blood loss of 1000 mL or less. 14 In the current study, 95% of controls had a blood loss of 1000 mL or less. Thus, the amount of blood loss in controls is very close to that indicated by the Japanese general survey (Fig. 1) . Consequently, MROP with or without suspicion of AP should be prohibited in the absence of appropriate hemostatic preparations in place given the large amount of blood loss that may potentially occur.
In the current study, the percentage of history of abortion and ART in MROP cases was relatively high. Although these have been referred to as causal risk factors for AP, 11, 15, 16 the diagnosis of AP cannot be achieved only by using these risk factors. In fact, there were no differences in risk factors such as history of abortion or history of ART between women with and without AP ( Table 2) . We have demonstrated the usefulness of a management protocol based on the prediction of AP using three ultrasonographic markers -bladder line interruption, absence of the retroplacental clear zone and placental lacunae. 17 However, findings such as bladder line interruption, placental lacunae and absence of the retroplacental clear zone were correlated with more invasive AP (placenta increta and percreta) in the group of placenta previa with or without risk factors such as a history of cesarean delivery, a history of uterine curettage or uterine anomalies. 17 Therefore, it is best not to use these prediction markers by ultrasonography for the detection of accreta vera. According to Andrew D, the differentiation between entrapment of placenta due to a closing cervix and AP can be achieved relatively straightforwardly by ultrasonography. 7 The key finding indicating entrapment of placenta is 'a small and contracted fundus', while the key finding indicating AP is 'thickened myometrium in all areas except where the placenta is located, where the myometrium will be thin'. Unfortunately, the number of cases in which ultrasound images were available was low in our series, and so, it was not possible to investigate its effectiveness. Instead, we found that 1980 mL of blood loss was the optimal cut-off value for detecting AP. To date, clinical findings of infection or inflammation during labor could be used as candidate markers besides ultrasound images. 18 In the current study, there was only one incidence of histological chorioamnionitis in 14 MROP cases with AP. If blood loss in MROP cases can be measured successively and accurately, this parameter could also be used as a potential new candidate marker.
We identified a case of AP with intractable bleeding followed by temporal cardiac arrest that was eventually diagnosed with an amniotic fluid embolism in the uterine corpus. It was postulated that the presence of abnormal placentation easily provides the laceration for amniotic fluid to enter the systemic circulation, thereby causing profound bleeding. 19 Apart from the current study, two similar incidences of amniotic fluid embolism in MROP cases have been reported. 20, 21 Although these two cases were not diagnosed as AP, the passage of fetal material may occur easily in cases involving a large amount of retained tissue, laceration of the maternal bed by MROP or artificial uterine contraction by uterine massage or use of oxytocin. It should be noted that MROP may be the cause of amniotic fluid embolism.
There were several limitations in our study. As the number of cases was low in our series, it will be necessary to increase this number in future investigations. In Japan, because retained placenta may be classified into categories such as 'placenta previa and abnormal placenta adherence' or 'uterine atony and unknown cause of disseminated intravascular coagulation (DIC)', 1 the actual influence of MROP on maternal morbidity is unknown. Henceforth, it will be necessary to establish a category of retained placenta in a national survey of maternal deaths or near-miss cases and to investigate its prognosis. As our study lacked ultrasonographic evaluations, we need to document cases involving these evaluations in an effort to validate its effectiveness.
In conclusion, the incidence of AP in MROP cases was high. The morbidity of MROP with unpredictable AP was severe. Even in cases where AP was not observed, the amount of total blood loss was sufficiently large. Therefore, MROP should be prohibited in the absence of appropriate hemostatic preparations in place. In practice, prompt hemostatic procedures may prevent further deterioration if the blood loss reaches 2035 mL in MROP cases where there is a high possibility of AP. Finally, further examinations for the detection of AP are desirable to achieve better prognoses.
